» Articles » PMID: 14609949

Dominant Role of Smooth Muscle L-type Calcium Channel Cav1.2 for Blood Pressure Regulation

Overview
Journal EMBO J
Date 2003 Nov 12
PMID 14609949
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Blood pressure is regulated by a number of key molecules involving G-protein-coupled receptors, ion channels and monomeric small G-proteins. The relative contribution of these different signaling pathways to blood pressure regulation remains to be determined. Tamoxifen-induced, smooth muscle-specific inactivation of the L-type Cav1.2 Ca2+ channel gene in mice (SMAKO) reduced mean arterial blood pressure (MAP) in awake, freely moving animals from 120 +/- 4.5 to 87 +/- 8 mmHg. Phenylephrine (PE)- and angiotensin 2 (AT2)-induced MAP increases were blunted in SMAKO mice, whereas the Rho-kinase inhibitor Y-27632 reduced MAP to the same extent in control and SMAKO mice. Depolarization-induced contraction was abolished in tibialis arteries of SMAKO mice, and development of myogenic tone in response to intravascular pressure (Bayliss effect) was absent. Hind limb perfusion experiments suggested that 50% of the PE-induced resistance is due to calcium influx through the Cav1.2 channel. These results show that Cav1.2 calcium channels are key players in the hormonal regulation of blood pressure and development of myogenic tone.

Citing Articles

Pharmacogenetic and pharmacokinetic factors for dexmedetomidine-associated hemodynamic instability in pediatric patients.

Guan Y, Li B, Zhang Y, Luo H, Wang X, Bai X Front Pharmacol. 2025; 15():1515523.

PMID: 39840108 PMC: 11745869. DOI: 10.3389/fphar.2024.1515523.


Ca signaling in vascular smooth muscle and endothelial cells in blood vessel remodeling: a review.

Suzuki Y, Giles W, Zamponi G, Kondo R, Imaizumi Y, Yamamura H Inflamm Regen. 2024; 44(1):50.

PMID: 39731196 PMC: 11673324. DOI: 10.1186/s41232-024-00363-0.


Rad-mediated inhibition of Ca1.2 channel activity contributes to uterine artery haemodynamic adaptation to pregnancy.

Hu X, Song R, Dasgupta C, Liu T, Zhang M, Twum-Barimah S J Physiol. 2024; 602(24):6729-6744.

PMID: 39612361 PMC: 11652214. DOI: 10.1113/JP287334.


Vascular Function and Ion Channels in Alzheimer's Disease.

Taylor J, Martin-Aragon Baudel M, Nieves-Cintron M, Navedo M Microcirculation. 2024; 31(7):e12881.

PMID: 39190776 PMC: 11498901. DOI: 10.1111/micc.12881.


Biomimetic Approaches in Scaffold-Based Blood Vessel Tissue Engineering.

Rosellini E, Giordano C, Guidi L, Cascone M Biomimetics (Basel). 2024; 9(7).

PMID: 39056818 PMC: 11274842. DOI: 10.3390/biomimetics9070377.


References
1.
Seisenberger C, Specht V, Welling A, Platzer J, Pfeifer A, Kuhbandner S . Functional embryonic cardiomyocytes after disruption of the L-type alpha1C (Cav1.2) calcium channel gene in the mouse. J Biol Chem. 2000; 275(50):39193-9. DOI: 10.1074/jbc.M006467200. View

2.
Hirasawa M, Pittman Q . Nifedipine facilitates neurotransmitter release independently of calcium channels. Proc Natl Acad Sci U S A. 2003; 100(10):6139-44. PMC: 156339. DOI: 10.1073/pnas.0936131100. View

3.
Davis M, Hill M . Signaling mechanisms underlying the vascular myogenic response. Physiol Rev. 1999; 79(2):387-423. DOI: 10.1152/physrev.1999.79.2.387. View

4.
Somlyo A, Wu X, Walker L, Somlyo A . Pharmacomechanical coupling: the role of calcium, G-proteins, kinases and phosphatases. Rev Physiol Biochem Pharmacol. 1999; 134:201-34. DOI: 10.1007/3-540-64753-8_5. View

5.
Kleppisch T, Nelson M . Adenosine activates ATP-sensitive potassium channels in arterial myocytes via A2 receptors and cAMP-dependent protein kinase. Proc Natl Acad Sci U S A. 1995; 92(26):12441-5. PMC: 40373. DOI: 10.1073/pnas.92.26.12441. View